2seventy bio (TSVT) Competitors $5.00 0.00 (0.00%) As of 05/13/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSVT vs. WVE, GYRE, PAHC, MLYS, COLL, SNDX, RCUS, ELVN, AVDL, and SYREShould you be buying 2seventy bio stock or one of its competitors? The main competitors of 2seventy bio include Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Phibro Animal Health (PAHC), Mineralys Therapeutics (MLYS), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Arcus Biosciences (RCUS), Enliven Therapeutics (ELVN), Avadel Pharmaceuticals (AVDL), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. 2seventy bio vs. Wave Life Sciences Gyre Therapeutics Phibro Animal Health Mineralys Therapeutics Collegium Pharmaceutical Syndax Pharmaceuticals Arcus Biosciences Enliven Therapeutics Avadel Pharmaceuticals Spyre Therapeutics 2seventy bio (NASDAQ:TSVT) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment. Does the media favor TSVT or WVE? In the previous week, Wave Life Sciences had 7 more articles in the media than 2seventy bio. MarketBeat recorded 11 mentions for Wave Life Sciences and 4 mentions for 2seventy bio. 2seventy bio's average media sentiment score of 1.63 beat Wave Life Sciences' score of 1.15 indicating that 2seventy bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 2seventy bio 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Wave Life Sciences 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer TSVT or WVE? Wave Life Sciences received 343 more outperform votes than 2seventy bio when rated by MarketBeat users. Likewise, 67.77% of users gave Wave Life Sciences an outperform vote while only 44.64% of users gave 2seventy bio an outperform vote. CompanyUnderperformOutperform2seventy bioOutperform Votes2544.64% Underperform Votes3155.36% Wave Life SciencesOutperform Votes36867.77% Underperform Votes17532.23% Which has more volatility & risk, TSVT or WVE? 2seventy bio has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -0.92, suggesting that its stock price is 192% less volatile than the S&P 500. Is TSVT or WVE more profitable? Wave Life Sciences has a net margin of -66.50% compared to 2seventy bio's net margin of -207.25%. 2seventy bio's return on equity of -53.65% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets 2seventy bio-207.25% -53.65% -23.67% Wave Life Sciences -66.50%-280.57%-52.90% Do analysts recommend TSVT or WVE? 2seventy bio currently has a consensus target price of $4.25, indicating a potential downside of 15.00%. Wave Life Sciences has a consensus target price of $21.17, indicating a potential upside of 250.44%. Given Wave Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Wave Life Sciences is more favorable than 2seventy bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 2seventy bio 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has stronger valuation and earnings, TSVT or WVE? Wave Life Sciences has higher revenue and earnings than 2seventy bio. 2seventy bio is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio2seventy bio$48.37M5.50-$217.57M-$0.10-50.00Wave Life Sciences$104.94M8.87-$57.51M-$0.84-7.19 Do insiders & institutionals believe in TSVT or WVE? 93.9% of 2seventy bio shares are owned by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are owned by institutional investors. 7.2% of 2seventy bio shares are owned by company insiders. Comparatively, 29.1% of Wave Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryWave Life Sciences beats 2seventy bio on 12 of the 19 factors compared between the two stocks. Get 2seventy bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSVT vs. The Competition Export to ExcelMetric2seventy bioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$266.15M$6.53B$5.38B$8.39BDividend YieldN/A2.64%5.21%4.10%P/E Ratio-2.698.9226.7619.71Price / Sales5.50252.24389.94117.54Price / CashN/A65.8538.2534.62Price / Book0.996.466.804.50Net Income-$217.57M$143.98M$3.23B$248.18M7 Day PerformanceN/A2.03%1.52%0.23%1 Month Performance0.20%4.11%10.04%12.39%1 Year Performance9.89%-2.87%16.73%7.07% 2seventy bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSVT2seventy bio1.5487 of 5 stars$5.00flat$4.25-15.0%N/A$266.15M$48.37M-2.69440Positive NewsWVEWave Life Sciences4.368 of 5 stars$6.60+0.2%$21.17+220.7%-4.4%$1.02B$108.30M-5.95240Positive NewsGap DownGYREGyre Therapeutics0.2804 of 5 stars$10.83+13.6%N/A-20.8%$1.02B$105.76M541.5040PAHCPhibro Animal Health3.5339 of 5 stars$24.50+9.0%$20.00-18.4%+26.6%$992.32M$1.11B51.041,860Positive NewsMLYSMineralys Therapeutics2.887 of 5 stars$15.01+2.5%$33.00+119.9%+29.0%$973.79MN/A-4.1228COLLCollegium Pharmaceutical4.0618 of 5 stars$29.56+2.3%$43.80+48.2%-14.6%$949.82M$631.45M12.74210Positive NewsSNDXSyndax Pharmaceuticals3.8313 of 5 stars$10.99+2.7%$35.91+226.7%-48.5%$945.66M$43.72M-3.03110Positive NewsRCUSArcus Biosciences3.55 of 5 stars$8.82+6.5%$25.67+191.2%-49.9%$933.38M$141M-2.80500Positive NewsGap DownHigh Trading VolumeELVNEnliven Therapeutics2.4841 of 5 stars$19.01+3.2%$40.33+112.2%-26.1%$932.75MN/A-10.0150Analyst RevisionAVDLAvadel Pharmaceuticals2.2233 of 5 stars$9.59+2.1%$19.43+102.6%-42.8%$926.67M$169.12M-12.1470Positive NewsSYRESpyre Therapeutics2.3332 of 5 stars$14.93+5.9%$51.17+242.7%-59.0%$899.92M$890,000.00-2.00100Positive NewsGap Down Related Companies and Tools Related Companies Wave Life Sciences Competitors Gyre Therapeutics Competitors Phibro Animal Health Competitors Mineralys Therapeutics Competitors Collegium Pharmaceutical Competitors Syndax Pharmaceuticals Competitors Arcus Biosciences Competitors Enliven Therapeutics Competitors Avadel Pharmaceuticals Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSVT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 2seventy bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 2seventy bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TSVT Stock Free TSVT Stock Alerts